These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 26615966)

  • 1. Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings.
    Johnson L; Manzardo AM; Miller JL; Driscoll DJ; Butler MG
    Am J Med Genet A; 2016 Mar; 170(3):594-601. PubMed ID: 26615966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher plasma orexin A levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls.
    Manzardo AM; Johnson L; Miller JL; Driscoll DJ; Butler MG
    Am J Med Genet A; 2016 Aug; 170(8):2097-102. PubMed ID: 27214028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher plasma orexin a levels in children with Prader-Willi syndrome compared with healthy unrelated sibling controls.
    Manzardo AM; Johnson L; Miller JL; Driscoll DJ; Butler MG
    Am J Med Genet A; 2016 Sep; 170(9):2328-33. PubMed ID: 27518917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma neurotensin levels in children with Prader-Willi syndrome.
    Butler MG; Nelson TA; Driscoll DJ; Manzardo AM
    Am J Med Genet A; 2015 Aug; 167A(8):1773-8. PubMed ID: 25847417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma chemokine levels in children with Prader-Willi syndrome.
    Butler MG; Hossain W; Sulsona C; Driscoll DJ; Manzardo AM
    Am J Med Genet A; 2015 Mar; 167A(3):563-71. PubMed ID: 25691409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin treatment in children with Prader-Willi syndrome: A double-blind, placebo-controlled, crossover study.
    Miller JL; Tamura R; Butler MG; Kimonis V; Sulsona C; Gold JA; Driscoll DJ
    Am J Med Genet A; 2017 May; 173(5):1243-1250. PubMed ID: 28371242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
    Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
    Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME.
    Butler MG; Nelson TA; Driscoll DJ; Manzardo AM
    J Rare Disord; 2015 Sep; 3(2):. PubMed ID: 27570781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
    Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
    Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
    Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
    Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
    Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
    Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between endogenous oxytocin and vasopressin levels and the Prader-Willi syndrome behaviour phenotype.
    Rice LJ; Agu J; Carter CS; Harris JC; Nazarloo HP; Naanai H; Einfeld SL
    Front Endocrinol (Lausanne); 2023; 14():1183525. PubMed ID: 37313445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising effects of oxytocin on social and food-related behaviour in young children with Prader-Willi syndrome: a randomized, double-blind, controlled crossover trial.
    Kuppens RJ; Donze SH; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):979-987. PubMed ID: 27486141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
    Goldstone AP; Holland AJ; Butler JV; Whittington JE
    Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of Prader-Willi syndrome on the family's quality of life and caregiving, and the unaffected siblings' psychosocial adjustment.
    Mazaheri MM; Rae-Seebach RD; Preston HE; Schmidt M; Kountz-Edwards S; Field N; Cassidy S; Packman W
    J Intellect Disabil Res; 2013 Sep; 57(9):861-73. PubMed ID: 23057501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.
    Roof E; Deal CL; McCandless SE; Cowan RL; Miller JL; Hamilton JK; Roeder ER; McCormack SE; Roshan Lal TR; Abdul-Latif HD; Haqq AM; Obrynba KS; Torchen LC; Vidmar AP; Viskochil DH; Chanoine JP; Lam CKL; Pierce MJ; Williams LL; Bird LM; Butler MG; Jensen DE; Myers SE; Oatman OJ; Baskaran C; Chalmers LJ; Fu C; Alos N; McLean SD; Shah A; Whitman BY; Blumenstein BA; Leonard SF; Ernest JP; Cormier JW; Cotter SP; Ryman DC
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1696-1708. PubMed ID: 36633570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin in young children with Prader-Willi syndrome: Results of a randomized, double-blind, placebo-controlled, crossover trial investigating 3 months of oxytocin.
    Damen L; Grootjen LN; Juriaans AF; Donze SH; Huisman TM; Visser JA; Delhanty PJD; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2021 May; 94(5):774-785. PubMed ID: 33296519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.
    Kweh FA; Miller JL; Sulsona CR; Wasserfall C; Atkinson M; Shuster JJ; Goldstone AP; Driscoll DJ
    Am J Med Genet A; 2015 Jan; 167A(1):69-79. PubMed ID: 25355237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obsessive-compulsive symptoms in Prader-Willi and "Prader-Willi-Like" patients.
    State MW; Dykens EM; Rosner B; Martin A; King BH
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):329-34. PubMed ID: 10087695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.